Neurocrine Biosciences' chief corporate affairs officer sells shares worth...

Published on 14 Feb 2025 on Investing.com

David W. Boyer, Chief Corporate Affairs Officer at Neurocrine Biosciences Inc. (NASDAQ:NBIX),...

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of 10 Top Insider Stock Buys And Sells In January. In this article, ...

Insider Monkey · via Yahoo Finance 18 Feb 2025

Neurocrine Biosciences' SWOT analysis: navigating growth amid market shifts

Investing.com 18 Feb 2025

Eric Benevich, the Chief Commercial Officer of Neurocrine Biosciences Inc (NASDAQ:NBIX), recently...

Investing.com 14 Feb 2025

David W. Boyer, Chief Corporate Affairs Officer at Neurocrine Biosciences Inc. (NASDAQ:NBIX),...

Investing.com 14 Feb 2025

SAN DIEGO—Gano Kyle, the Chief Executive Officer of Neurocrine Biosciences Inc. (NASDAQ:NBIX), a...

Investing.com 14 Feb 2025

SAN DIEGO—Stephen A. Sherwin, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), a $11.4...

Investing.com 14 Feb 2025

This ETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio. Looking a...

Zacks · via Yahoo Finance 3 Feb 2025

Insider Activity Recap: Wednesday's Top Buys and Sells in US Stocks

Investing.com 30 Jan 2025

Kevin Charles Gorman, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), recently sold a...

Investing.com 29 Jan 2025

On Monday, Neurocrine Biosciences, Inc. (NASDAQ:NBIX) amended its agreement with Takeda...

Benzinga · via AOL 28 Jan 2025